<b>Gapping up</b><br/><u>In reaction to strong earnings/guidance</u>: MG +8.3%, LULU +8.2% (also target raised to $70 from $63 at FBR Capital), ZLC +5.2% (also upgraded to Hold from Sell at Soleil), FUL +4.1%, CALD +3.6%, RFMI +3.6%, QLGC +1.9% (also NE to replace QLGC in S&P 500; downgraded to Hold from Buy at Canaccord), SNX +1.5% (also upgraded to Strong Buy from Buy at Needham). <br/><br/><u>Select financial related names showing notable strength</u>: BBVA +6.5%, STD +5.8%, IRE +4.0%, DB +3.3%, HBC +2.9%, BCS +2.9%, CS +2.5%, ING +2.5%, UBS +2.3%, DB +2.2%, AIG +2.2%, LYG +2.2%, PUK +2.2%, AEG +1.9%, MBI +1.7%, BAC +1.4%, JPM +1.3% (CEO Jamie Dimon, on CNBC, says they're going to be putting up a lot of excess capital, would like to reinstate a dividend), C +0.8%. <br/><br/><u>Select metals/mining stocks trading higher</u>: NXG +3.0%, SLT +2.9%, FRG +2.5%, NG +2.2% (Cramer makes positive comments on MadMoney), MT +2.0%, GRS +1.9% (announce that its drilling program at the Mezquite Project in northeast Zacatecas state, Mexico, has discovered significantly anomalous mineralization), PZG +1.8%, BBL +1.7%, BHP +1.5%, RIO +1.1%. <br/><br/><u>Select oil/gas related names showing strength:</u> NE +3.0% (to replace QLGC in S&P 500), REP +2.8% (traded higher for second day overseas), RIG +1.9%, DO +1.4%, E +1.4%, TOT +1.2%, WFT +1.2%. <br/><br/><u>Select European drug names seeing modest strength</u>: SNY +2.0%, RHHBY +1.6%, NVS +1.0%. <br/><br/><u>Other news</u>: CREG +15.2% (thinly traded; scheduled to present at Piper conf this afternoon), PSTI +15.1% (continued strength), CDII +14.1% (announced that its magnesium segment operations received new purchase contracts valued at ~$31 mln in its 1Q11), ITT +13.7% (announces plan to separate into three independent publicly traded companies), APWR +8.2% (receives $13.6 mln construction agreement for Tesco in Yingkou, China; signs $43 mln EPC Contract with China Resources Land), VRML +7.6% (announces issuance of patent for peripheral artery disease), MTXX +4.6% (Porter Orlin submits letter to the Board regarding HIG acquisition; believes deal undervalues co), SQNM +4.2% (strength attributed British Medical Journal (BMJ) article discussing results from study on fetal trisomy 21), SILC +3.1% (new design wins from major customer to boost co's revs by ~$2 mln/year), TEF +2.1% (reports out that the co is planning to launch mobile phone service in Costa Rica), SNN +2.1% (still checking for anything new; reports out earlier this week that JNJ considered bid for the company), CRED +1.7% (following yesterday's 15%+ jump).<br/><br/><u>Analyst comments</u>: SYMC +1.8% (upgraded to Buy from Hold at Citigroup), CCL +1.2% (added to Conviction Buy List at Goldman), VZ +0.7% (upgraded to Buy from Neutral at Goldman).